Literature DB >> 16988017

CTX-M-3 and CTX-M-15 extended-spectrum beta-lactamases in isolates of Escherichia coli from a hospital in Algiers, Algeria.

Nadjia Ramdani-Bouguessa1, Nuno Mendonça, Joana Leitão, Eugénia Ferreira, Mohamed Tazir, Manuela Caniça.   

Abstract

Sixteen strains of Escherichia coli isolated between January and June 2005 in a hospital in Algiers carry the ISEcp1 element and the TEM and either CTX-M-3 (n=3) or CTX-M-15 (n=13) beta-lactamases. Fourteen of the isolates are multidrug resistant. Five isolates from the neonatal ward were indistinguishable by pulsed-field gel electrophoresis.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16988017      PMCID： PMC1698418          DOI： 10.1128/JCM.01445-06

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  19 in total

1.  Plasmid-mediated extended-spectrum beta-lactamase (CTX-M-3 like) from India and gene association with insertion sequence ISEcp1.

Authors:  A Karim; L Poirel; S Nagarajan; P Nordmann
Journal:  FEMS Microbiol Lett       Date:  2001-07-24       Impact factor: 2.742

2.  Biochemical analysis of the ceftazidime-hydrolysing extended-spectrum beta-lactamase CTX-M-15 and of its structurally related beta-lactamase CTX-M-3.

Authors:  Laurent Poirel; Marek Gniadkowski; Patrice Nordmann
Journal:  J Antimicrob Chemother       Date:  2002-12       Impact factor: 5.790

3.  Clinical isolates of Enterobacteriaceae producing extended-spectrum beta-lactamases: prevalence of CTX-M-3 at a hospital in China.

Authors:  Hui Wang; Swathi Kelkar; Weiyuan Wu; Minjun Chen; John P Quinn
Journal:  Antimicrob Agents Chemother       Date:  2003-02       Impact factor: 5.191

4.  Nosocomial outbreak caused by Salmonella enterica serotype Livingstone producing CTX-M-27 extended-spectrum beta-lactamase in a neonatal unit in Sousse, Tunisia.

Authors:  Olfa Bouallègue-Godet; Youssef Ben Salem; Laëtitia Fabre; Marie Demartin; Patrick A D Grimont; Ridha Mzoughi; François-Xavier Weill
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

5.  Multidrug-resistant Salmonella enterica serotype Senftenberg isolates producing CTX-M beta-lactamases from Constantine, Algeria.

Authors:  Thierry Naas; Abdesselam Lezzar; Chafia Bentchouala; Farida Smati; Jean-Michel Scheftel; Henri Monteil; Patrice Nordmann
Journal:  J Antimicrob Chemother       Date:  2005-06-20       Impact factor: 5.790

6.  CTX-M-15, OXA-30 and TEM-1-producing Escherichia coli in two Portuguese regions.

Authors:  Nuno Mendonça; Deolinda Louro; Ana Paula Castro; José Diogo; Manuela Caniça
Journal:  J Antimicrob Chemother       Date:  2006-03-10       Impact factor: 5.790

7.  Plasmid-mediated TEM-3 extended-spectrum beta-lactamase production in Salmonella typhimurium in Casablanca.

Authors:  Rajaa AitMhand; Abdelaziz Soukri; Najat Moustaoui; Hamid Amarouch; Naima ElMdaghri; Danielle Sirot; Mohamed Benbachir
Journal:  J Antimicrob Chemother       Date:  2002-01       Impact factor: 5.790

8.  CTX-M-15 extended-spectrum (beta)-lactamase from Nigerian Klebsiella pneumoniae.

Authors:  Olusegun O Soge; Anne Marie Queenan; Kayode K Ojo; Bolanle A Adeniyi; Marilyn C Roberts
Journal:  J Antimicrob Chemother       Date:  2005-11-30       Impact factor: 5.790

9.  High rate of fatal cases of pediatric septicemia caused by gram-negative bacteria with extended-spectrum beta-lactamases in Dar es Salaam, Tanzania.

Authors:  Bjørn Blomberg; Roland Jureen; Karim P Manji; Bushir S Tamim; Davis S M Mwakagile; Willy K Urassa; Maulidi Fataki; Viola Msangi; Marit G Tellevik; Samwel Y Maselle; Nina Langeland
Journal:  J Clin Microbiol       Date:  2005-02       Impact factor: 5.948

10.  Ceftazidime-hydrolysing CTX-M-15 extended-spectrum beta-lactamase (ESBL) in Poland.

Authors:  Anna Baraniak; Janusz Fiett; Waleria Hryniewicz; Patrice Nordmann; Marek Gniadkowski
Journal:  J Antimicrob Chemother       Date:  2002-09       Impact factor: 5.790
View more
  16 in total

1.  Community-associated Escherichia coli harboring CTX-M β-lactamases from urine cultures from pediatric patients.

Authors:  Krystina L Woods; James R Johnson; Sofia Padkowsky; Noriel Mariano; Rita Colon-Urban; Mahmoud Hassanein; Wehbeh Wehbeh; Brian D Johnston; Connie Clabots; Saadia Zahid; Carl Urban
Journal:  Antimicrob Agents Chemother       Date:  2012-01-17       Impact factor: 5.191

2.  Role of SHV β-lactamase variants in resistance of clinical Klebsiella pneumoniae strains to β-lactams in an Algerian hospital.

Authors:  Nadjia Ramdani-Bouguessa; Vera Manageiro; Daniela Jones-Dias; Eugénia Ferreira; Mohamed Tazir; Manuela Caniça
Journal:  J Med Microbiol       Date:  2011-03-17       Impact factor: 2.472

3.  Extended-spectrum β-lactamase-producing Enterobacteriaceae in Cameroonian hospitals.

Authors:  C M Lonchel; P Melin; J Gangoué-Piéboji; M-C O Assoumou; R Boreux; P De Mol
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-08-11       Impact factor: 3.267

4.  Spread of extended-spectrum beta-lactamase CTX-M-producing escherichia coli clinical isolates in community and nosocomial environments in Portugal.

Authors:  Nuno Mendonça; Joana Leitão; Vera Manageiro; Eugénia Ferreira; Manuela Caniça
Journal:  Antimicrob Agents Chemother       Date:  2007-03-19       Impact factor: 5.191

5.  First description of OXA-48-producing Escherichia coli and the pandemic clone ST131 from patients hospitalised at a military hospital in Algeria.

Authors:  A Agabou; A Pantel; Z Ouchenane; N Lezzar; S Khemissi; D Satta; A Sotto; J-P Lavigne
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-05-05       Impact factor: 3.267

6.  IL-10 administration reduces PGE-2 levels and promotes CR3-mediated clearance of Escherichia coli K1 by phagocytes in meningitis.

Authors:  Rahul Mittal; Ignacio Gonzalez-Gomez; Ashok Panigrahy; Kerstin Goth; Richard Bonnet; Nemani V Prasadarao
Journal:  J Exp Med       Date:  2010-05-24       Impact factor: 14.307

7.  Prevalence characterization of extended-spectrum beta-lactamases among Escherichia coli isolates collected in Zhengzhou.

Authors:  Zhijian Zhang; Xiaobing Guo; Qinxian Zhang
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352

8.  Inhibition of inducible nitric oxide controls pathogen load and brain damage by enhancing phagocytosis of Escherichia coli K1 in neonatal meningitis.

Authors:  Rahul Mittal; Ignacio Gonzalez-Gomez; Kerstin A Goth; Nemani V Prasadarao
Journal:  Am J Pathol       Date:  2010-01-21       Impact factor: 4.307

9.  First description of Escherichia coli producing CTX-M-15- extended spectrum beta lactamase (ESBL) in out-patients from south eastern Nigeria.

Authors:  Ifeanyichukwu R Iroha; Charles O Esimone; Sandra Neumann; Lennart Marlinghaus; Miriam Korte; Florian Szabados; Sören Gatermann; Martin Kaase
Journal:  Ann Clin Microbiol Antimicrob       Date:  2012-07-23       Impact factor: 3.944

10.  Outbreak of colonizations by extended-spectrum β-lactamase-producing Escherichia coli sequence type 131 in a neonatal intensive care unit, Italy.

Authors:  Mario Giuffrè; Domenico Cipolla; Celestino Bonura; Daniela Maria Geraci; Aurora Aleo; Stefania Di Noto; Federica Nociforo; Giovanni Corsello; Caterina Mammina
Journal:  Antimicrob Resist Infect Control       Date:  2013-03-21       Impact factor: 4.887
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.